Transcriptional signatures related to glucose and lipid metabolism predict 
treatment response to the tumor necrosis factor antagonist infliximab in 
patients with treatment-resistant depression

Mehta, Divya; Raison, Charles L.; Woolwine, Bobbi J.; Haroon, Ebrahim; Binder, Elisabeth B.; Miller, Andrew H.; Felger, Jennifer C.

doi:10.1016/j.bbi.2013.04.004

Lokale TagsFreigabegeschichteDetailsÜbersicht

Transcriptional signatures related to glucose and lipid metabolism predict treatment response to the tumor necrosis factor antagonist infliximab in patients with treatment-resistant depression

Mehta, D., Raison, C. L., Woolwine, B. J., Haroon, E., Binder, E. B., Miller, A. H., et al. (2013). Transcriptional signatures related to glucose and lipid metabolism predict treatment response to the tumor necrosis factor antagonist infliximab in patients with treatment-resistant depression. BRAIN BEHAVIOR AND IMMUNITY, 31, 205-215. doi:10.1016/j.bbi.2013.04.004.

Item is Freigegeben

einblenden: alle ausblenden: alle

Basisdaten

einblenden: ausblenden:

Datensatz-Permalink: https://hdl.handle.net/11858/00-001M-0000-0014-CD4F-2 Versions-Permalink: https://hdl.handle.net/11858/00-001M-0000-0018-D54B-4

Genre: Zeitschriftenartikel

ausblenden:

Urheber:
Mehta, Divya¹, Autor
Raison, Charles L.², Autor
Woolwine, Bobbi J.², Autor
Haroon, Ebrahim², Autor
Binder, Elisabeth B.¹, Autor
Miller, Andrew H.², Autor
Felger, Jennifer C.², Autor

Affiliations:
1AG Binder, Elisabeth, Florian Holsboer (Direktor), Max Planck Institute of Psychiatry, Max Planck Society, ou_1607142
2external, ou_persistent22